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Hepatocyte growth factor (HGF) modulates matrix turnover in
human glomeruli.
Background. The imbalance between synthesis and degrada-
tion of mesangial matrix causes glomerulosclerosis and leads to
renal failure. Hepatocyte growth factor (HGF) has been shown
to reduce the progression in murine models of chronic renal
failure. The present study evaluated the effect of HGF on the
extracellular matrix turnover and on c-met receptor in human
glomeruli.
Methods. Human glomeruli microdissected from donor kid-
ney biopsies before transplantation were incubated with cul-
ture media containing HGF (50 ng/mL). After 24 and 48 hours,
the expression of c-met, (a2) IV collagen, transforming growth
factor-b (TGF-b), metalloprotease (MMP) 2 and 9 and of
the inhibitor of MMP-2, tissue inhibitors of metalloprotease-1
(TIMP-1), was evaluated by polymerase chain reaction (PCR).
b-actin was used as housekeeping gene. The production of col-
lagen type IV and TGF-b was evaluated by enzyme-linked
immunosorbent assay (ELISA) and Western blotting and the
activity of MMP by zymography.
Results. (a2) IV collagen, TGF-b , and TIMP-1 mRNA lev-
els were markedly decreased in glomeruli treated with HGF
at 24 and 48 hours. The expression of c-met was up-regulated
by HGF treatment. HGF reduced the production of collagen
type IV and TGF-b . MMP-2 but not MMP-9 mRNA level was
increased in HGF-treated glomeruli, although the gelatinolytic
activity of the supernatant was not changed. By light micro-
scopic examination kidney biopsies neither showed glomerular
hypercellularity nor mesangial expansion.
Conclusion. HGF reduced expression and synthesis of TGF-
b and collagen type IV and increased MMP-2 mRNA level in
normal human glomeruli. These results suggest an antifibrotic
effect of HGF on glomerular cells and may explain its beneficial
role in glomerulosclerosis.
1See Editorial by Striker, p. 2500.
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Hepatocyte growth factor (HGF) is a pleiotropic fac-
tor, which plays a central role in organogenesis and de-
velopment [1]. HGF stimulates angiogenesis and cell mi-
gration, effects that are crucial in tumor invasiveness
[2]. Morphogenic and motogenic properties are favored
by the capacity of HGF to accelerate extracellular ma-
trix turnover inducing the expression of metalloproteases
(MMPs) [3]. The possibility to modulate extracellular ma-
trix turnover has prompted several studies to evaluate
the effects of HGF in animal models of chronic renal dis-
ease. HGF has been shown to reduce renal injury in rats
with unilateral ureteral obstruction [4] and in the remnant
kidney model of chronic renal disease [5]. However this
antifibrotic effect has not been confirmed by Takayama,
Larochelle, and Sabnis [6] who demonstrated that mice
transgenic for HGF developed glomerulosclerosis. Con-
tradictory results arise also from in vitro studies showing
increased production of matrix in mesothelial and en-
dothelial cells [7] [abstract; Esposito C et al, J Am Soc
Nephrol 10:570A, 1999] or conversely inhibition of tubu-
lar epithelial to myofibroblast transition by HGF [8].
The aim of the present study was to evaluate the ef-
fect of HGF on the extracellular matrix turnover in iso-
lated human glomeruli. We found that HGF reduced (a2)
IV collagen and transforming growth factor-b (TGF-b)
mRNA levels and proteins and increased the expression
of MMP-2 but did not change gelatinolytic activity. Fi-
nally, HGF treatment up-regulated glomerular expres-
sion of the receptor c-met. These effects confirm a specific
antifibrotic action of HGF at glomerular level.
METHODS
Isolation of human glomeruli
Human glomeruli were isolated by microdissection
from renal cortex of five donor kidneys just before trans-
plantation. At the same time a little core of tissue was
obtained for histologic study, formalin fixed and paraf-
fin embedded; 3 to 4 lm sections were stained with
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Table 1. Primer sequences and PCR cycles
Gene Sense primers Antisense primers Cycles
Collagen IV (a 2) 5′-TATTCCTTCCTCATGCACACGGCG-3′ 5′-CCAATTTTTGGGTTGGCACC-3′ 38
TGF-b 5′-GGAGGGGAAATTGAGGGCTTTCGC-3′ 5′-TTATGCTGGTTGTACAGGGC-3′ 38
MMP-2 5′-CCACATTCTGGCCTGAGCTCCC-3′ 5′-GATTTGATGCTTCCAAACTTCAC-3′ 40
MMP-9 5′-CACTGTCCACCCCTCAGAGC-3′ 5′-GCCACTTGTCGGCGATAAGG-3′ 40
TIMP-1 5′-AATTCCGACCTCGTCATCAGG-3′ 5′-ACTGGAAGCCCTTTTCAGAGC-3′ 38
c-Met 5′-GGAAACACCCATCCAGAATGTCATT-3′ 5′-TGATATCGAATGCAATGGATGATCT-3′ 35
b-actin 5′-CCCCAGGCACCAGGGCGTGAT-3′ 5′-GGTCATCTTCTCGCGGTTGGCCTTGGGGT. 33
Abbreviations are: TGF-b , transforming growth factor-b ; MMP-2, metalloprotease 2; MMP-9, metalloprotease 9; TIMP-1, tissue inhibitors of metalloprotease-1.
hematoxylin-eosin, periodic acid-Schiff (PAS) and Mas-
son’s trichrome. In order to isolate glomeruli a small
piece of renal cortex was placed immediately at 4◦C in
saline solution containing RNase inhibitors. Glomeruli
were microdissected and washed three times in cold saline
solution; pools of five glomeruli were then transferred to
sterile Eppendorf tubes and cultured with RPMI medium
containing fetal calf serum (FCS) (10%) and HGF (50
ng/mL). Glomeruli incubated with medium without HGF
were used as control. Since glomerular size varied, in pre-
liminary experiments several pools of five glomeruli were
prepared from the same kidney, individually reverse tran-
scribed and fractions of cDNAs were amplified before
and after pooling the cDNA in a single tube. No difference
was observed between the pools of five glomeruli and
the pools of cDNA suggesting that pooling five glomeruli
blunted the differences in RNA yield.
Extracellular matrix turnover and c-met expression
Extracellular matrix turnover is a continual process
deriving from the balance between deposition of ma-
trix components and removal by enzymatic degradation.
This process is further regulated by molecules that mod-
ulate the activity of collagenase such as tissue inhibitors
of metalloproteases (TIMPs). One of the most impor-
tant factors in the accumulation of extracellular matrix
is TGF-b , which plays a central role in fibrosis. In or-
der to evaluate the effect of HGF on matrix turnover we
measured the expression of (a2) IV collagen, MMP-2 and
MMP-9, TIMP-1, and TGF-b in human glomeruli treated
with HGF for 24 and 48 hours. The effect of HGF on
the expression of its receptor was also evaluated. Briefly,
isolated glomeruli (five glomeruli/tube) were incubated
with HGF-containing medium for 24 and 48 hours. At
the end of the incubation time glomeruli were washed,
freeze/thawed three times in presence of Triton X-100
(2%) and centrifuged (20,000g). Supernatant (9 lL) was
reverse transcribed in situ using a First Strand cDNA Syn-
thesis Kit (AMV) (Roche Diagnostic GmbH, Mannheim,
Germany). Oligo(dT) was used to prime the reverse tran-
scription (RT) for subsequent mRNA amplification. The
reaction mixture was incubated at 60◦C for 60 minutes
and the reverse trascriptase was inactivated by heating
the reaction at 90◦C for 7 minutes. cDNA (2 lL) was
amplified by polymerase chain reaction (PCR) using the
primers and the cycles indicated in Table 1 [9]. PCR was
performed using the cDNA Amplification Kit (Labora-
toires Eurobio, Toulouse, France) and an initial reaction
was carried out for each gene to determine the final mag-
nesium concentration. To determine the number of cycles
required for each gene and ascertain that amplification
was in the logarithmic linear phase preliminary reactions
were performed using different amplification cycles and
different amount of starting material. A linear correla-
tion between signal intensity and amplification cycles in-
dicated that amplification was in the logarithmic part of
PCR reaction (Fig. 1). Amplification program consisted
of a first incubation of 3 minutes at 94◦C followed by
cycles of the following steps: denaturation at 94◦C for 1
minute, annealing at 60◦C for 1 minute, and extension at
72◦C for 3 minutes. The final incubation was performed
at 72◦C for 7 minutes. PCR products were separated by
agarose (2%) gel electrophoresis, stained with ethidium
bromide, identified by ultraviolet light and measured by
densitometry. To further prevent variations due to differ-
ent RNA yield between samples, RNA degradation and
cDNA synthesis, we also used b-actin as a standard to
assure equal synthesis of cDNA in different samples and
the results were analyzed as ratios sample gene/b-actin.
Zymography for 72 and 92 kD (MMP-2 and MMP-9)
MMP activity was evaluated by zymography as de-
scribed previously [10]. Briefly glomeruli were incubated
with medium containing HGF for 24 and 48 hours. At the
end of the incubation time they were further incubated
in serum-free medium containing 0.1% bovine serum al-
bumin (BSA) for 24 hours. The supernatant was then
collected, concentrated 10 times using a 22 kD cut-off
filter (Millipore, Milan, Italy). An aliquot (32 lL) was
loaded onto a 10% gelatin polyacrylamide gel. After elec-
trophoresis the gel was incubated in Triton X-100 buffer
and activated in development buffer for 24 hours at 37◦C.
Gelatinase activity was visualized by staining the gel with
Coomassie brilliant blue. The level of MMPs was quanti-
fied by densitometry.
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Fig. 1. Representative agarose gel electrophoresis of amplified prod-
ucts obtained with different polymerase chain reaction (PCR) cycles.
PCR for b-actin is shown. Data points are means of three reactions.
ELISA for type IV collagen and TGF-b
Type IV collagen production was evaluated by enzyme-
linked immunosorbent assay (ELISA) on the super-
natant of the samples used for RT-PCR assay using
rabbit antihuman type IV collagen antibody as previ-
ously described [10]. Briefly, glomeruli were incubated
with medium containing HGF for 24 and 48 hours in Ep-
pendorf tubes. Glomeruli incubated with medium with-
out HGF were used as control. At the end of incubation
time Eppendorf tubes were centrifuged. While glomeruli
underwent RT-PCR the supernatant was collected and
used for ELISA. The 96-well plates were coated with
supernatant (100 lL) and incubated overnight at 4◦C.
Rabbit antihuman type IV collagen antibody (1:1000) was
then added for 11/2 hours followed by biotin-conjugated
goat antirabbit IgG (1:5000) and alkaline phosphatase-
conjugated streptavidin (1:2500) (obtained from Sigma,
Milan, Italy). Finally p-nitrophenyl phosphate was added
for 30 minutes. Optical density was assessed at 405 nm us-
ing a Multiskan MCC/340 plate reader. The concentration
of collagen type IV was calculated from a standard curve
made with known amount of collagen. TGF-b production
was determined using the commercial Quantikine TGF-
b ELISA kit in accordance with the protocol specified
by the manufacturer (R&D Systems, Minneapolis, MN,
USA).
Immunoblot analysis for TGF-b
Glomeruli were washed with cold phosphate-buffered
saline (PBS) before being lysated with 100 lL cold lysis
buffer [10% glycerol, 20 mmol/L Tris, 140 mmol/L NaCl,
10 mmol/L sodium pyrophosphate, 10 mmol/L sodium
fluoride, 2 mmol/L sodium orthovanadate, and 3 mmol/L
ethylenediaminetetraacetic acid (EDTA)] containing 1%
Triton X-100, aprotinin, leupeptin, phenylmethylsulfonyl
Fig. 2. Representative histology of kidneys from which glomeruli have
been microdissected. Periodic acid-Schiff (PAS) staining (magnification
40×).
fluoride (PMSF), and benzamidin. Glomerular lysates
were incubated for 45 minutes at 4◦C, and the insoluble
material was removed by centrifugation at 20,000g for
30 minutes at 4◦C. Protein concentration in the lysates
was determined using the DC Protein Assay reagent
(Bio-Rad, Milan, Italy). The samples were then sepa-
rated by 10% sodium dodecyl sulfate-polyacrylamide gel
elctrophoresis (SDS-PAGE) and transferred to nitrocel-
lulose membranes. The membranes were incubated with
the anti-TGF-b antibody (1:200) (Santa Cruz Biotech-
nology, Santa Cruz, CA, USA) overnight and then with
peroxidase-conjugated goat antirabbit secondary anti-
body (1:2000) for 1 hour. Immunoreactive proteins were
visualized with an enhanced chemiluminescence (ECL)
Western blotting detection system (SuperSignal West
Dura extended Duration Substrate) (Pierce Biotechnol-
ogy, Inc., Rockford, IL, USA).
Statistical analysis
All the experiments described in the Methods section
were carried out in duplicate or triplicate Eppendorf
tubes for each of the five donor kidneys. PCR reactions,
protein assays, and Western blot were run three times
for each molecule in separate experiments. Data are ex-
pressed as mean ± SD. Two-tailed unpaired Student t test
was used to measure differences between HGF-treated
and control glomeruli. P < 0.05 was considered statisti-
cally significant.
RESULTS
Light microscopy of renal biopsy specimens obtained
from each of the five kidneys used for microdissec-
tion showed an average of 35 glomeruli/section. None
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Fig. 3. Effect of hepatocyte growth factor
(HGF) on the expression of a2 (IV) colla-
gen, transforming growth factor-b (TGF-b),
and b-actin mRNA levels in isolated human
glomeruli. Glomeruli were treated with me-
dia containing HGF (50 ng/mL) for 24 and 48
hours and the mRNA levels were determined
as a ratio sample gene/b-actin gene by densit-
ometric analysis as described in the Methods
section. Results are expressed as mean ± SD.
∗∗P < 0.01 vs. control.
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Fig. 4. Effect of hepatocyte growth factor
(HGF) on type IV collagen release in isolated
human glomeruli. Glomeruli were treated
with media containing HGF (50 ng/mL) for 24
and 48 hours. Untreated glomeruli (CT) were
used as controls. Media were then changed
with media containing fetal calf serum (FCS)
(0.1%) and HGF (50 ng/mL). After further
24 hours incubation, media were collected
and assayed for type IV collagen by enzyme-
linked immunosorbent assay (ELISA).
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Fig. 5. Effect of hepatocyte growth fac-
tor (HGF) on transforming growth factor-b
(TGF-b) protein in isolated human glomeruli.
Glomeruli were treated with media contain-
ing HGF (50 ng/mL) for 24 and 48 hours.
Untreated glomeruli (CT) were used as con-
trols. (A) Media were then replaced with me-
dia containing fetal calf serum (FCS) (0.1%)
and HGF (50 ng/mL). After further 24 hours,
media were collected and assayed for TGF-b
using a preformed kit. Results are expressed
as mean ± SD. ∗P < 0.05 vs. control. (B) At
48 hours, cell membranes were solubilized.
Protein samples were separated by gel elec-
trophoresis and immunoblot was performed
as described in the Methods section.
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Fig. 6. Effect of hepatocyte growth factor
(HGF) on metalloprotease (MMP) 2 and 9
mRNA levels in human glomeruli. Glomeruli
were treated with HGF (50 ng/mL) for 24 and
48 hours and the mRNA levels were deter-
mined as a ratio MMP/b-actin by densitomet-
ric analysis as described in the Methods sec-
tion. Results are expressed as means ± SD. ∗P
< 0.05 vs. control.
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Fig. 7. Effect of hepatocyte growth factor
(HGF) on tissue inhibitor of metalloprotease-
1 (TIMP-1) mRNA levels in human glomeruli.
Glomeruli were treated with HGF (50 ng/mL)
for 24 and 48 hours and the mRNA levels
were determined as a ratio TIMP-1/b-actin
gene by densitometric analysis as described in
the Methods section. Results are expressed as
means ± SD. ∗P < 0.05; ∗∗P < 0.01 vs. control.
of the glomeruli showed mesangial cell hypercellular-
ity. Mesangial matrix, tuft lumina, and basement mem-
branes showed no pathologic changes. At higher power
there was no endothelial swelling. None of the glomeruli
showed epithelial cell proliferation, synechia or crescents
in the Bowman space (Fig. 2). These data confirmed
that glomeruli used for the experiments were normal
glomeruli.
Treatment of glomeruli with HGF induced a reduction
of (a2) IV collagen expression both at 24 and at 48 hours
compared to untreated glomeruli (Fig. 3). The reduced
expression was paralleled by a slight decreased produc-
tion of collagen type IV in the supernatant. However, the
reduction of collagen synthesis was not apparent before
48 hours of incubation (Fig. 4).
It has been suggested that one of the mechanisms by
which HGF reduces fibrosis may be the inhibition of
TGF-b synthesis. We wondered if HGF could reduce
TGF-b expression and production on human glomeruli.
After 24 and 48 hours of incubation TGF-b mRNA and
protein levels were markedly down-regulated in HGF-
treated glomeruli compared to control (Figs. 3 and 5).
Degradation of extracellular matrix is a very impor-
tant step in matrix remodeling. Reduction of protease
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Fig. 8. Zymography of conditioned medium from isolated human
glomeruli treated with hepatocyte growth factor (HGF) (50 ng/mL).
Untreated glomeruli were used as controls. The upper lane represents
metalloprotease (MMP)-9, the lower lane MMP-2. Molecular weight is
shown on the left.
activity and/or increased expression of their inhibitors
(TIMP) may induce matrix accumulation. These consid-
erations led us to evaluate MMPs and TIMPs expression
in glomeruli treated with HGF. While the expression of
MMP-9 was not changed by HGF both at 24 and 48 hours,
the expression of MMP-2 was significantly increased at 48
hours (Fig. 6). The increased expression of MMP-2 was
paralleled by a reduction in the expression of TIMP-1 af-
ter 24 and 48 hours (Fig. 7). However, gelatinase activity
in the supernatant of glomeruli treated with HGF was not
changed compared to the supernatant from the untreated
glomeruli (Fig. 8).
We found that glomeruli expressed HGF receptor c-
met and mRNA levels were not changed by incubation
with HGF at 24 hours. However, the decrease of mRNA
levels observed at 48 hours in control glomeruli was sig-
nificantly reduced by adding HGF (Fig. 9).
DISCUSSION
Glomerulosclerosis is the final common step of the ma-
jority of pathological processes affecting glomeruli [11].
The accumulation of extracellular matrix is caused by
an imbalance between synthesis and degradation of ma-
trix [12]. Although HGF has been suggested to reduce
glomerulosclerosis and interstitial fibrosis in animal mod-
els of chronic progressive nephropathy, not all studies
have been confirmatory. Thus the role of HGF in scle-
rotic processes is not yet clear. In the present study we
have evaluated the effects of HGF on the turnover of ex-
tracellular matrix on isolated human glomeruli. Our re-
sults confirm an antifibrotic role of HGF. The expression
of (a2) IV collagen was significantly reduced by HGF;
furthermore, the reduced expression was associated with
a decreased production of collagen type IV. Collagen
type IV is the major component of extracellular matrix
in glomeruli and studies in mice suggest a correlation be-
tween the level of type IV collagen mRNA and the degree
of sclerosis [13].
Apart for an increased synthesis, accumulation of col-
lagen may result from a reduced degradation. MMPs are
a family of matrix-degrading enzymes that play a piv-
otal role in matrix remodeling. They have been isolated
in the supernatant of human glomeruli and are involved
in renal development and disease [14]. We found that
HGF up-regulated MMP-2 mRNA in human glomeruli.
The increased expression of MMP-2 was paralleled by a
decrease of TIMP-1 mRNA level. Unexpectantly, zymo-
graphic analysis, performed on the supernatant, failed to
show a difference between MMP activity of HGF-treated
and untreated glomeruli. The lack of a difference as well
as the slight but not significant decrease of collagen type
IV may be due to the shortness of the incubation time. Al-
ternatively MMPs may have been trapped and released
very slowly by the glomeruli and only a glomerular lysates
analysis could have shown a significant difference.
Our experiments suggest that HGF-induced reduction
in extracellular matrix deposition is mediated by a de-
creased synthesis of matrix components paralleled by a
mild increased of their degradation. These findings only
partially confirm those found by Liu et al [15] who showed
an increased expression of MMP-9 but not of MMP-2
and a reduction of TIMPs in human renal epithelial cells
stimulated by HGF. Liu et al suggested that HGF pre-
served renal structure only by activating matrix degra-
dation pathways. These differences may be explained by
the models used. Isolated human glomeruli may be con-
sidered sort of coculture, surely different from a cell line
such as that used by Liu et al in his experiments. The re-
sults obtained with isolated glomeruli are derived by the
effects of HGF on three different cell types, mesangial,
epithelial, and endothelial cells. Each cell type may re-
spond differently to HGF but what we observed in our
experiments was the overall effect of HGF on glomeruli
[10].
TGF-b is widely recognized as a modulator of organ
fibrosis after tissue injury [16].The expression of this cy-
tokine has been correlated with collagen type IV deposi-
tion and fibrosis in in vitro and in vivo studies [17, 18]
as demonstrated in the unilateral ureteral obstruction
model in mice. The administration of neutralizing anti-
body against mouse HGF in the unilateral ureteral ob-
struction model was associated with an increase of TGF-
b and fibrosis. On the other hand, the administration of
recombinant human HGF suppressed TGF-b production
and attenuated the progression of renal injury [4]. These
results clearly suggest that the antifibrotic role of HGF
may take place through modulation of TGF-b expression
when the latter is up-regulated by a previous tissue injury.
Our results demonstrate a reduction of TGF-b mRNA
and protein in normal human glomeruli treated with HGF
further confirming its antifibrogenic effect and suggesting
that the inhibition of TGF-b production may be one of
the mechanisms by which HGF exerts its protective role.
To date this is the first study that evaluates the effect of
HGF in isolated normal glomeruli excluding further in-
fluence of infiltrating cells. Furthermore, since glomeruli
were microdissected from perfused kidneys just before
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Fig. 9. Effect of hepatocyte growth factor
(HGF) on the expression of c-met and b-actin
by isolated human glomeruli. Glomeruli were
treated with HGF for 24 and 48 hours and the
mRNA levels were determined as a ratio c-
met/b-actin gene by densitometric analysis as
described in the Methods section. Results are
expressed as mean ± SD. ∗P < 0.05 vs. control.
transplantation we can exclude the presence of blood-
borne cells as demonstrated by the histologic studies of
the kidneys from which the glomeruli were dissected.
Thus, the effects we observed were derived only from
HGF stimulation of glomerular resident cells. The results
of our study may help understanding the physiologic role
played by HGF in regulating matrix turnover in normal
conditions.
Several lines of evidence indicate that genetic factors
play a central role in the development and progression
of glomerular diseases and that the molecular analysis of
glomeruli isolated from biopsies may further improve our
understanding of the underlying disorders [9, 19]. With
the present study we cannot determine if HGF may over-
come the up-regulation of extracellular matrix compo-
nent dependent on the genetic background. However,
in an animal model of spontaneous nephropathy, the re-
duction of HGF level was paralleled by an expansion of
collagen-deposited areas and an increased of TGF-b lev-
els suggesting that HGF may at least blunt the effects of
genetic factors [20].
HGF exerts its biologic functions after binding the
receptor c-met. The latter has been demonstrated in
renal tubular and glomerular cells by immunohistochem-
istry and Northern blot analysis [21–23]. Our results
demonstrate that c-met mRNA is expressed in whole hu-
man glomeruli. Moreover, the down-regulation of c-met
mRNA levels observed at 48 hours in untreated glomeruli
is blunted by incubation with HGF. To date we are the first
demonstrating a regulation of c-met by HGF at glomeru-
lar level. The difference observed at 48 hours may be
due to a positive feedback of HGF on c-met receptor
trascription.
CONCLUSION
Our results demonstrate that HGF down-regulates
the expression and production of type IV collagen and
TGF-b , furthermore HGF up-regulates the expression
of MMP-2 and decreases that of TIMP-1. These findings
indicate an antifibrotic effect of HGF on isolated human
glomeruli and suggest HGF as a potential therapeutic
molecule in glomerular remodeling.
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